Department of Radiology, Utrecht University Medical Center, Utrecht, The Netherlands.
Eur Radiol. 2013 Aug;23(8):2228-35. doi: 10.1007/s00330-013-2833-y. Epub 2013 Apr 17.
To investigate the feasibility of subtractionless first-pass single contrast medium dose (0.1 mmol/kg) peripheral magnetic resonance angiography (MRA) at 1.5 T using two-point Dixon fat suppression and compare it with conventional subtraction MRA in terms of image quality.
Twenty-eight patients (13 male, 15 female; mean age ± standard deviation, 66 ± 16 years) with known or suspected peripheral arterial disease underwent subtractionless and subtraction first-pass MRA at 1.5 T using two-point Dixon fat suppression. Results were compared with regard to vessel-to-background contrast. A phantom study was performed to assess the signal-to-noise ratio (SNR) of both MRA techniques. Two experienced observers scored subjective image quality. Agreement regarding subjective image quality was expressed in quadratic weighted κ values.
Vessel-to-background contrast improved in all anatomical locations with the subtractionless method versus the subtraction method (all P < 0.001). Subjective image quality was uniformly higher with the subtractionless method (all P < 0.03, except for the aorto-iliac arteries for observer 1, P = 0.052). SNR was 15 % higher with the subtractionless method (31.9 vs 27.6).
This study demonstrates the feasibility of subtractionless first-pass single contrast medium dose lower extremity MRA. Moreover, both objective and subjective image quality are better than with subtraction MRA.
• MRA is increasingly used for vascular applications. • Dixon imaging offers an alternative to image subtraction for fat suppression. • Subtractionless first-pass peripheral MRA is possible using two-point Dixon fat suppression. • Subtractionless peripheral MRA is possible at 1.5 T a single contrast medium dose. • Subtractionless first-pass peripheral MRA provides good image quality with few non-diagnostic studies.
研究两点 Dixon 脂肪抑制技术在 1.5T 磁共振设备下无减影技术的单次外周应用的可行性,采用低对比剂剂量(0.1mmol/kg),并与传统减影磁共振血管成像(MRA)比较,以评估图像质量。
28 例患者(13 例男性,15 例女性;平均年龄±标准差,66±16 岁),患有或疑有外周动脉疾病,采用两点 Dixon 脂肪抑制技术在 1.5T 磁共振设备下进行无减影和减影技术的外周单次首过 MRA 检查。评估两种技术的血管与背景对比,对两种 MRA 技术的信噪比(SNR)进行了体模研究。两位经验丰富的观察者对主观图像质量进行评分。使用二次加权κ值评估主观图像质量的一致性。
与减影技术相比,无减影技术在所有解剖部位的血管与背景对比均得到改善(均 P<0.001)。无减影技术的主观图像质量普遍更高(均 P<0.03,观察者 1 的主动脉-髂动脉除外,P=0.052)。无减影技术的 SNR 提高了 15%(31.9 比 27.6)。
本研究证明了在 1.5T 磁共振设备下采用低对比剂剂量(0.1mmol/kg)行无减影技术的外周单次首过 MRA 的可行性。而且,客观和主观图像质量均优于减影 MRA。
•磁共振血管成像(MRA)在外周血管疾病中的应用日益广泛。• Dixon 成像为脂肪抑制的替代方法,无需图像减影。•两点 Dixon 脂肪抑制技术可实现无减影的外周单次首过 MRA。• 1.5T 磁共振设备下可实现无减影的外周单次首过 MRA,使用低对比剂剂量。• 无减影的外周单次首过 MRA 可提供高质量的图像,且非诊断性研究较少。